- AU$75.72m
- AU$56.86m
- AU$5.09m
Annual cashflow statement for Orthocell, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | C2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 2.54 | 3.02 | 2.95 | 2.23 | 25.2 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -4.18 | -5.26 | -4.52 | -6.26 | 14.6 |
| Capital Expenditures | -0.369 | -0.055 | -0.189 | -0.535 | -0.632 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.369 | -0.055 | -0.189 | -0.535 | -0.632 |
| Financing Cash Flow Items | -0.666 | -0.66 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 12.9 | 14.5 | 0.594 | 1.49 | -0.165 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.33 | 9.21 | -4.11 | -5.31 | 13.8 |